|
Continuing product development is of course essential to a
pharmaceutical company's success. But other factors are fuelling
the demand for research.
The expectation that
future therapies will be more effective and safer inevitably
requires a greater depth of development work.
In addition,
relatively new areas of research are developing rapidly, for
example special group testing. Awareness is growing that different
groups - children, the elderly, ethnic groups - respond differently
to drugs. As a result, regulatory authorities increasingly require
more studies to determine the efficacy and safety of the drug for
such groups.
Pharmaceutical
companies worldwide outsource around one quarter of their
research and development budgets. Half of these outsourced funds
are spent with medium-sized contract research organisations, and
significantly this share is increasing. This perhaps recognises
smaller companies' ability to deliver enhanced customer service,
better value for money, greater flexibility and speed of response.
These are exactly the
qualities
we offer at Sequani.
Sharing our
expertise
Our vision is to share our expertise with a wider audience. We aim to continue expanding our local
network of healthcare professionals, including general practitioners and
hospital consultants. We envisage a facility that can be used by all
customers for pharmaceutical and medical device studies, or simply for
seeking expert advice quickly. |
